ProCE Banner Activity

Beyond the Exam Room: Patient and HCP Perspectives on Barriers to HBV Care in the United States

Clinical Thought
In this commentary, a patient and healthcare provider discuss their experiences with barriers to HBV care in the United States and key action items to address to reduce those barriers.

Released: June 22, 2022

Expiration: June 21, 2023

Share

Faculty

Mindie H. Nguyen

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine (GI & Hepatology, Liver Transplant)
Professor of Epidemiology & Population Health
(by Courtesy)
Director of Hepatology Clerkship
Faculty Search LENS Advocates,
Stanford Department of Medicine
Faculty Fellow, Stanford Center for Innovation
in Global Health
Member, Stanford Cancer Institute, Maternal &
Child Health Research Institute, & Stanford Bio-C
Stanford, California
Past Chair: HBV SIG, The American Association for the Study of Liver Diseases (AASLD)
28th President: The International Association for the Study of the Liver (IASL)

Jennifer Wild

Jennifer Wild, MS, BSN, RN, OCN

Clinical Nurse – GI Medical Oncology
UCSF Cancer Center
San Francsico, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from:

Gilead Sciences, Inc.

Partners

AHF

ProCE Banner

Hepatitis B Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine (GI & Hepatology, Liver Transplant)
Professor of Epidemiology & Population Health
(by Courtesy)
Director of Hepatology Clerkship
Faculty Search LENS Advocates,
Stanford Department of Medicine
Faculty Fellow, Stanford Center for Innovation
in Global Health
Member, Stanford Cancer Institute, Maternal &
Child Health Research Institute, & Stanford Bio-C
Stanford, California
Past Chair: HBV SIG, The American Association for the Study of Liver Diseases (AASLD)
28th President: The International Association for the Study of the Liver (IASL)

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD, has disclosed that she has received funds for research support from Gilead Sciences and Vir and consulting fees from Exact Sciences, Gilead Sciences, Janssen, Lilly, Novartis, and Spring Bank.

Jennifer Wild, MS, BSN, RN, OCN

Clinical Nurse – GI Medical Oncology
UCSF Cancer Center
San Francsico, California

Jennifer Wild, MS, BSN, RN, OCN, has disclosed that she has received consultant, advisor, and speaker fees from MJH Life Sciences.